drugset / Trial / NCT02093689
Intraoperative Floppy Iris Syndrome Undergoing Intraocular Lens Replacement Surgery
Non-randomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the effect of OMS302 on the signs of Intraoperative Floppy Iris Syndrome in patients at risk.
Timeline
- Start
- 2014-02
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketorolac | Other / unclassified | 4.24 mg/ml | Other |
| Subject | Phenylephrine | Small molecule | 12.37 mg/ml | Other |